The emotional and psychological impact of multiple sclerosis relapses

Foong, 1998, Neuropsychological deficits in multiple sclerosis after acute relapse, J Neurol Neurosurg Psychiatry, 64, 529, 10.1136/jnnp.64.4.529 Dalos, 1983, Disease activity and emotional state in multiple sclerosis, Ann Neurol, 13, 573, 10.1002/ana.410130517 Schiaffino, 1998, Examining the impact of illness representations on psychological adjustment to chronic illness, Health Psychol, 17, 262, 10.1037/0278-6133.17.3.262 Wineman, 1996, Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trial, Appl Nurs Res, 9, 53, 10.1016/S0897-1897(96)80413-7 Devins, 1996, Psychosocial impact of illness intrusiveness moderated by age in multiple sclerosis, Psychol Health Med, 1, 179, 10.1080/13548509608400017 Devins, 1993, Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis, J Psychosom Res, 37, 163, 10.1016/0022-3999(93)90083-R Devins, 1993, Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis, J Nerv Mental Dis, 181, 377, 10.1097/00005053-199306000-00007 Kalb, 2005, When MS joins the family LaRocca, 2005, Emotional and cognitive issues Jacobs, 2000, Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group, N Engl J Med, 343, 898, 10.1056/NEJM200009283431301 Comi, 2001, Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study, Lancet, 357, 1576, 10.1016/S0140-6736(00)04725-5 Kappos, 2005, Betaferon® in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT): clinical results Barkhof, 2005, Betaferon® in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT): magnetic resonance imaging outcomes Deatrick, 1998, Mothers with multiple sclerosis and their children: effects of fatigue and exacerbations on maternal support, Nurs Res, 47, 205, 10.1097/00006199-199807000-00005 Goeb, 2006, Psychiatric side effects of interferon-beta in multiple sclerosis, Eur Psychiatry, 21, 186, 10.1016/j.eurpsy.2005.09.013 Patten, 2005, The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis, Mult Scler, 11, 175, 10.1191/1352458505ms1144oa Gold, 2005, The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study, Eur J Neurol, 12, 649, 10.1111/j.1468-1331.2005.01083.x Northrop, 2005, Planning wisely for possible care needs Cooper, 2005, Life planning: financial and legal considerations